Health & Wellness

Press Releases

Dr. Mohamad Cherry of Atlantic Health System to Lead Meeting Session of Multiple Studies at Top International Blood Cancer Conference

c9baf18461d2d1e41e62_Dr._Mohamad_Cherry.jpg
Dr. Mohamad Cherry Credits: Atlantic Health
c9baf18461d2d1e41e62_Dr._Mohamad_Cherry.jpg

Mohamad Cherry, MD, will lead a major session on new discoveries about the most common type of acute adult leukemia and help present results of four major blood cancer studies at the American Society of Hematology (ASH) 59th Annual Meeting, December 9-12 in Atlanta, GA.  The meeting is the world’s pre-eminent gathering of clinicians and researchers focused on blood diseases, who travel from nearly 100 countries to hear the latest research developments.

An internationally known hematology/oncology researcher, Dr. Cherry recently joined Atlantic Hematology Oncology, part of Atlantic Health System’s Atlantic Medical Group at Morristown Medical Center’s Carol G. Simon Cancer Center, from the University of Oklahoma Health Sciences Center’s Stephenson Cancer Center.  There, he held a number of senior appointments, and conducted pioneering research on leukemia and lymphoma drugs and other cancer research.    

“I look forward to helping lead this discussion of pioneering research on acute myeloid leukemia and interacting with so many of the world’s leading blood cancer researchers at the ASH meeting,” said Dr. Cherry.  “It is truly an honor to play such as leading role in this major conference.”

Sign Up for E-News

Dr. Cherry will serve as co-moderator, with Krzysztof Mrózek, MD, PhD of The Ohio State University, of a session the morning of December 9, entitled “Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Prognostic Information and Therapeutic Implication.”  Dr. Cherry will help lead discussion on study results presented by six international research teams looking at underlying mechanisms and potential strategies for treating acute myeloid leukemia (AML).  AML is the most common type of acute leukemia in adults, which also occurs in children and is difficult to treat.  Presentations will cover such topics as an analysis of certain genetic mutations and responsiveness to chemotherapy, and the evaluation of specific foreign substances in the body that may be new immunotherapeutic targets in pediatric AML. 

“We are building a world-class cancer treatment and research team at Atlantic Health System,” said Eric Whitman, MD, medical director, Atlantic Health System Cancer Care.  “Dr. Cherry’s prominent role in this year’s ASH conference is the latest of many examples of our oncology and hematology leadership.”

Dr. Cherry has served as a clinical investigator on numerous major studies, including four that will be presented at the ASH meeting.  One presentation will present the first results of the ongoing Acute Leukemia Epidemiology, Survival and Endpoints (ALESE) study, which is examining various characteristics of participants in a large multicenter clinical trial.  A second presentation will discuss preliminary results from an ongoing Phase I/II clinical trial of a novel drug being tested in patients with advanced blood cancers.  In a third study, Dr. Cherry and colleagues will present research analyzing the response of patients, based on their levels of white blood cells known as lymphocytes, to a type of immunotherapy.  In addition, Dr. Cherry will help present preliminary results from a Phase I study of a new molecularly targeted treatment combined with intensive chemotherapy for newly diagnosed AML.    

Background on Dr. Cherry

Prior to joining Atlantic Health System Cancer Care, where he will add to the team’s ability to treat leukemia, lymphoma and myeloma, Dr. Cherry held appointments as associate professor of medicine (hematology/oncology), director of the hematology/oncology fellowship program, Mai Eager Anderson Endowed Chair in clinical trials and co-chair of the Academy of Teaching Scholars Faculty Development, Education and Mentoring Committee at the University of Oklahoma Health Sciences Center Stephenson Cancer Center. He also co-chaired the Leukemia Working Group at the Sarah Cannon Research Institute Blood Cancer Consortium. As principal investigator of multiple clinical trials, Dr. Cherry has performed groundbreaking research in the development of new therapeutics for relapsed and refractory blood cancers.  He has also focused his research on studying epigenetics as biomarkers for response to chemotherapy in osteosarcoma.  He has led Phase I, II and III clinical trials, funded by the National Cancer Institute and pharmaceutical companies.

Dr. Cherry has published a number of books and book chapters, and has served as lead author or co-author of more than 20 peer-reviewed papers published in leading scientific journals. He has lectured locally, nationally and internationally, and has presented or published his research at premier hematology/oncology meetings sponsored by ASH and the American Society of Clinical Oncology (ASCO), among others.

Dr. Cherry is the recipient of numerous awards for his research, clinical and educational pursuits, including ASH HONORS for Hematology Opportunities for the Next Generation of Research Scientists (as a mentor) and the Medal of Excellency from the Board of Specialization and Academic Orientation – Lebanese University, Beirut.  In 2015, he was selected as Hematology Advocate by the ASH Advocacy Leadership Institute.

With specialty training from some of the nation’s leading medical educators and researchers, Dr. Cherry completed clinical rotations in the leukemia department at MD Anderson Cancer Center and a fellowship in hematology/oncology at the Oklahoma University Health Sciences Center Stephenson Cancer Center, where he was elected chief fellow of the Section of Hematology and Oncology. He completed two residencies – an internal medicine residency at Staten Island University Hospital and a laboratory medicine residency at the American University of Beirut Medical Center in Lebanon.  Dr. Cherry earned his medical degree from Lebanese University, where he was third in his class. Dr. Cherry also received a Master’s of Science degree in clinical and translational research from Oklahoma University College of Public Health.

Dr. Cherry continues to serves as a mentor and advisor to fellows, residents and medical students.  He contributes to continuing education, public health, and professional development.

Dr. Cherry is a physician with Atlantic Hematology Oncology at the Carol G. Simon Cancer Center -Morristown Medical Center campus.  He can be reached at (973) 971-7960.

About Atlantic Health System

Atlantic Health System, headquartered in Morristown, N.J., is an integrated health care delivery system powered by a workforce of 16,000 team members dedicated to building healthier communities. The system is comprised of 350 sites of care, including six hospitals: Morristown Medical Center, Overlook Medical Center, Newton Medical Center, Chilton Medical Center, Hackettstown Medical Center and Goryeb Children’s Hospital. Atlantic Health System also supports communities through Atlantic Medical Group, Atlantic Rehabilitation, Atlantic Home Care and Hospice, and its subsidiary, Atlantic Ambulance Corporation. Atlantic Health System sponsors the Atlantic Accountable Care Organization, one of the larger ACOs in the nation, and Optimus Healthcare Partners. 

TAP Into Another Town's News:

You May Also Be Interested In

Sign Up for E-News

Parsippany

Reduce Your Risk for Colorectal Cancer

April 25, 2018

Morristown Medical Center’s Carol G. Simon Cancer Center presents “Protecting Your Colorectal Health” on Tuesday, May 1from 6:00 to 8:00pm at the Morristown Medical Center Health Pavilion, 333 Mount Hope Avenue in Rockaway. Admission is free.

This popular, educational program presents an opportunity to hear up-to-date presentations from leading ...

Prosecutor Fredric Knapp and Chief Assistant Prosecutor Brad Seabury Conduct Opioid Presentation at First Presbyterian Church in New Vernon

On Sunday, April 22, 2018 Morris County Prosecutor Fredric Knapp and Chief Assistant Prosecutor Brad Seabury gave a presentation on the Opioid and Heroin Epidemic at the First Presbyterian Church in New Vernon. Approximately 25 parishioners attended the one hour presentation following their morning service.

Prosecutor Knapp welcomed those attending and thanked the Church for hosting the event.

GFWC Woman's Club Participates in Denville Rid Litter Day

GFWC Woman’s Club- Denville/Rockaway Participates in Denville PRIDE Rid Litter Day

Close to 400 volunteers came out on a lovely, but windy Saturday to participate in Denville Township’s annual PRIDE, Rid Litter Day.  The timing was perfect, as it also coincides with the 48th anniversary of Earth Day! Earth Day is an annual event created to celebrate the planet's ...

FREE MORRIS COUNTY VETERANS LEGAL CLINIC AND BENEFITS EXPO

APRIL 27 EVENT OPEN TO VETS FROM ALL 39 MORRIS TOWNS

A free Morris County Veterans Legal Clinic and Resources Expo will be on Friday, April 27 at the Morristown Municipal Building, hosted by the Morris County Bar Foundation and Morris County Veterans’ Services Office, in cooperation with the Town of Morristown.

The clinic/expo will run from 11 a.m. to 2 p.m. at the town hall at 200 ...

Morris County Prosecutor’s Office Police Use of Force and Officer Involved Shooting Program is a Great Success

MORRIS COUNTY, NJ - On the afternoon of Tuesday, April 17, 2018, the Morris County Prosecutor’s Office hosted the first of their four “21-County, 21st Century Community Policing Project” programs. The “21/21 Community Policing Project” was implemented by New Jersey Attorney General Gurbir Grewal and aims to cultivate relationships between local law enforcement ...

MORRIS HISTORY: NEW RESEARCH TO TELL STORY OF MORRIS CANALS AND PORT DELAWARE

MORRIS HISTORY: NEW RESEARCH TO TELL STORY OF MORRIS CANALS

AND PORT DELAWARE

Register Now: April 28 Canals and Local History Symposium is Selling Out

Newly acquired letters, documents and drawings reveal an untold story of the daily operations of the Morris Canal, a thoroughfare that was considered a technological marvel in the 1800s for its innovative use of water-driven inclined ...

Upcoming Events

Sat, May 5, 9:00 AM

First Presbyterian Church of Succasunna, Succasunna

Pre-Owned Treasures Sale At First Presbyterian ...

Other

Carousel_image_41347cce18723101343a_rfl-logo

Sat, May 5, 4:00 PM

Morristown Armory, Morristown

Relay For Life of Greater Morristown

Giving Back Health & Wellness

Thu, May 10, 5:30 PM

The Atrium, Florham Park

Disrupt / NNJ

Business & Finance

An Innovative Tenure Recognized: Former County Clerk Joseph J. Bell

MORRISTOWN, NJ - Voting by Telephone is something that sounds like a 2018 initiative but in fact it was the brain child of the sole living former County Clerk's - Joseph J. Bell.  On Wednesday evening, April 18, 2018, surrounded by family and his former staff, Bell was honored at current Morris County Clerk Ann Grossi’s “Through the Ages” tribute in ...

Assemblyman Jon Bramnick Makes a Career Day Visit to New Providence

NEW PROVIDENCE, NJ - Assemblyman Jon Bramnick helped the kids at the New Providence Middle School answer the age-old question - What do you want to be when you grow up?  The Assembly Leader spent the day with the students talking about what it's like to be a NJ State Legislaturor and an attorney during their annual Career Day.  The kids were interested and ...